Background
Boneâanchored hearing systems (BAHSs) are widely used for hearing rehabilitation and are indicated in cases of conductive and mixed hearing loss and in singleâsided deafness. The Ponto system, that is one available option, has been on the market since 2009.
Objective of review
The aim of this study is to systematically review the literature reporting on the Ponto system, with regard to audiological and surgical outcomes and patient's qualityâofâlife scores.
Type of review
A systematic literature search was performed in the PubMed database 2009âJuly 2019.
Search strategy
Search term: ((osseointegrated hearing aid) OR (bone conduction implant) OR (bone anchored hearing) OR BAHA OR BAHS OR BAHI). Preâdefined inclusion and exclusion criteria were applied.
Evaluation method
Englishâlanguage articles reporting original clinical data (audiological, surgical or qualityâofâlife outcomes) on the Ponto system were included.
Articles reporting on Ponto and another BAHS system where the results on Ponto constituted less than 50% of the patient population or including only results on testband or softband devices were excluded.
Results
Audiological outcomes were discussed in 20 publications. Improvement against the unaided thresholds was demonstrated. The functional improvement was on average 33.9 dB. The effective gain or remaining airâbone gap was on average 6.7 dB. All evaluated data showed aided speech reception thresholds significantly below normal speech level. Twentyâseven publications reported surgical and followâup data for the Ponto system. Implant survival was 97.7%, adverse skin reactions (Holgers â„ 2) were 5% across visits and 15% across patients. No complications were lifeâthreatening, causing permanent disability/damage or requiring a hospitalisation. Five studies reported quality of life using the Glasgow benefit inventory, 98% reported an improvement when analysing the score on an individual level.
Conclusions
The outcomes of this systematic review confirm that percutaneous systems provide consistent audiological benefits and improved quality of life for patients. Further, the review demonstrates that the percutaneous systems are safe, with relatively low complication rates. Skinârelated complications are the most common complication type and are experienced by approximately one patient out of seven, or in less than one of 20 followâup visits.